Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,402 | -167,475 | -143,137 | -162,308 | -33,135 |
| Depreciation Amortization | 1,076 | 4,628 | 2,734 | 1,882 | 1,218 |
| Accounts receivable | 8,805 | -17,016 | -6,146 | -1,947 | 756 |
| Other Working Capital | -11,052 | -71,072 | -42,970 | -913 | -921 |
| Other Operating Activity | 2,706 | 72,955 | 62,756 | 110,682 | 6,630 |
| Operating Cash Flow | $-52,867 | $-177,979 | $-126,763 | $-52,604 | $-25,453 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -274,905 | -156,217 | -91,872 | -91,243 | -51,668 |
| PPE Investments | -211 | -1,521 | -559 | -177 | -141 |
| Purchase Of Investment | N/A | -1,400 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 103,116 | 40,125 | N/A | N/A |
| Other Investing Activity | 0 | -2,775 | -2,775 | -2,775 | 0 |
| Investing Cash Flow | $-275,115 | $-58,796 | $-55,080 | $-94,195 | $-51,809 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 172 | 172 | 172 | N/A |
| Common Stock Issued | 164,738 | 466,756 | 339,817 | 339,560 | 213,416 |
| Other Financing Activity | -3,835 | -1,648 | -1,648 | 303 | 97 |
| Financing Cash Flow | $160,903 | $465,280 | $338,340 | $340,035 | $213,513 |
| Exchange Rate Effect | -14 | 27 | 6 | 0 | N/A |
| Beginning Cash Position | 250,728 | 22,196 | 22,196 | 22,196 | 22,196 |
| End Cash Position | 83,634 | 250,728 | 178,700 | 215,433 | 158,447 |
| Net Cash Flow | $-167,094 | $228,532 | $156,504 | $193,237 | $136,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,867 | -177,979 | -126,763 | -52,604 | -25,453 |
| Capital Expenditure | -211 | -1,521 | -559 | -177 | -141 |
| Free Cash Flow | -53,078 | -179,500 | -127,321 | -52,781 | -25,594 |